Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  SMART QUOTES
Smart Quotes      
Glenmark Pharmaceuticals Ltd.
  Industry : Pharmaceuticals & Drugs
BSE Code 532296
ISIN Demat INE935A01035
Book Value 879.93
NSE Code GLENMARK
Dividend Yield % 0.13
Market Cap 566151.26
P/E 38.08
EPS 52.69
Face Value 1  
BSE NSE
04-Sep-2025 10:36
Last Price 2010.95
Net Change 5.75
% Change 0.29%
Prev.Close 2005.20
Open 2036.25
High 2036.25
Low 1980.00
Volume 10072
Value 20254288.4
Best Buy 2009.65
Best Sell 2010.90
Best Quantity 2
Sell Quantity 1
Today's Range 2036.25
52-Week High 2286.15
52-Week Low 1274.70
Today | 1W | 1M | 1Y  
You need to upgrade your Flash Player
Best Bid Best Offer
Quantity 2
Price 2009.65
Quantity 1
Price 2010.90
Holding Details
More
Latest Corporate Events
Bonus 1 : 1   04-Mar-05  
Book Closure 17-Sep-24   27-Sep-24  
Dividend 250 %   15-Sep-25  
Company News
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.